Profile
LYRA NVO VRTX REGN SGEN ARGX
Company Name Lyra Therapeutics, Inc. Novo Nordisk A/S Vertex Pharmaceuticals Incorporated Regeneron Pharmaceuticals, Inc. Seagen Inc. argenx SE
Sector Healthcare Healthcare Healthcare Healthcare Healthcare Healthcare
Industry Biotechnology Biotechnology Biotechnology Biotechnology Biotechnology Biotechnology
Market Cap $11.28M $358.71B $105.12B $77.21B $43.15B $38.03B
Employees 0.09K 71.88K 5.40K 14.17K 3.26K 1.15K
CEO Dr. Maria Palasis Ph.D. Mr. Lars Fruergaard Jorgensen Dr. Reshma Kewalramani FASN, M.D. Dr. Leonard S. Schleifer M.D., Ph.D. Mr. David R. Epstein B.Sc., M.B.A. Mr. Timothy Van Hauwermeiren EMBA, M.Sc.
Ratings
LYRA NVO VRTX REGN SGEN ARGX
Quant Rating Score 1 3 3 4 3 1
Quant Rating Strong Sell Neutral Neutral Buy Neutral Strong Sell
Trading
LYRA NVO VRTX REGN SGEN ARGX
Last Close $0.1723 $87.37 $408.18 $714.47 $228.74 $629.99
High 52 $6.53 $146.91 $516.74 $1201.76 $228.74 $638.33
Low 52 $0.17 $85 $392.81 $701.85 $228.74 $356.01
Price vs. 52 Week High -97.36 % -40.53 % -21.01 % -40.55 % 0 % -1.31 %
Price vs. 52 Week Low 1.35 % 2.79 % 3.91 % 1.8 % 0 % 76.96 %
Total Return
LYRA NVO VRTX REGN SGEN ARGX
1 Month Return -13.11 % -17.68 % -12.61 % -5.12 % 0 % 3.76 %
3 Month Return -28.62 % -29.71 % -11.87 % -31.3 % 0 % 20.09 %
6 Month Return -35.47 % -39.19 % -13.89 % -33.17 % 0 % 41.29 %
9 Month Return -97.19 % -32.49 % -2.46 % -25.85 % 0 % 58.46 %
YTD Return -96.71 % -15.54 % 0.32 % -18.65 % 0 % 65.6 %
1 Year Return 0 % 0 % 0 % 0 % 0 % 0 %
3 Year Return 0 % 0 % 0 % 0 % 0 % 0 %
5 Year Return 0 % 0 % 0 % 0 % 0 % 0 %
Dividends
LYRA NVO VRTX REGN SGEN ARGX
Dividend Yield Percentage (TTM) - 1.59 % - - - -
Dividend Paid and Capex Coverage Ration (TTM) -24.42 % 1.25 % -2.62 % 4.88 % -2.27 % -2.22 %
Dividend Per Share (TTM) - 9.9 % - - - -
Payout Ratio (TTM) - 46.6 % - - - -
Growth
LYRA NVO VRTX REGN SGEN ARGX
Asset Growth 29.67 % 30.35 % 25.23 % 13.23 % -1.21 % 44.93 %
Gross Profit Growth 426.35 % 32.32 % 9.64 % 6.49 % 22.93 % 190.7 %
Revenue Growth 14.31 % 31.26 % 10.51 % 7.76 % 24.65 % 198.56 %
Revenue 3 Year - 90.03 % 60.36 % 55.67 % 91.56 % 2071.96 %
Revenue 5 Year -84.24 % 123.63 % 219.55 % 110.3 % 215.48 % 3041.46 %
Revenue 10 Year -84.24 % 65.69 % 610.45 % 549.62 % 494.04 % 9009.53 %
EBIT Growth -19.21 % 37.11 % 0 % -14.6 % 10.13 % 40.94 %
Net Income Growth -13.39 % 50.71 % 8.96 % -8.87 % 9.51 % 58.42 %
Net Income 3 Yeari Growth Per Share 50.96 % 106.26 % 34.59 % 13.48 % -763.59 % 64.01 %
Net Income 5 Yeari Growth Per Share -30.81 % 133.27 % 70.33 % 74.02 % -276.93 % -143.65 %
Net Income 10 Yeari Growth Per Share -30.81 % 98.1 % 809.6 % 871.12 % -624.16 % -857 %
Operating Income Growth -19.21 % 37.11 % 0 % -14.6 % 10.13 % 40.94 %
Operating Cash Flow Growth (CFG) -45.91 % 38.06 % -14.35 % -8.39 % 9.07 % 51.28 %
Operating 3 Year CFG 48.36 % 117.73 % 9.63 % 76.95 % -147.99 % 21.71 %
Operating 5 Year CFG -19.96 % 162.84 % 174.78 % 125.17 % -195.86 % -329.63 %
Operating 10 Year CFG -19.96 % 150.28 % 6084.35 % 713.56 % -2622.09 % -1280.2 %
EPS Growth 31.15 % 51.88 % 8.33 % -8.54 % 10.81 % 60.46 %
EPS Diluted Growth 31.15 % 52.37 % 8.35 % -9.03 % 10.81 % 60.46 %
Book Value Per Share -32.78 % 28.67 % 25.58 % 15.03 % -9.83 % 38.53 %
Share Holder 3 Year Equity Growth Per Share -79.3 % 74.77 % 104.06 % 137.56 % 33.72 % 93.75 %
Share Holder 5 Year Equity Growth Per Share 110.51 % 121.34 % 291.14 % 219.1 % 220.81 % 318.81 %
Share Holder 10 Year Equity Growth Per Share 110.51 % 49.24 % 1030.79 % 1286.9 % 691.19 % 3654.06 %
Dividend Per Share Growth - 26.56 % - - - -
Dividend 3 Year Growth Per Share - 63.98 % - - - -
Dividend 5 Year Growth Per Share - 79.57 % - - - -
Dividend 10 Year Growth Per Share - 94.94 % - - - -
Debt Growth 1113.04 % 4.74 % 44.1 % 0.06 % -23.28 % 60.95 %
Free Cash Flow Growth -47.77 % 9.17 % -16.47 % -17.11 % 3.67 % 51.98 %
Updated On 31 Dec 2023 31 Dec 2023 31 Dec 2023 31 Dec 2023 31 Dec 2022 31 Dec 2023
Profitability
LYRA NVO VRTX REGN SGEN ARGX
Gross Profit Margin TTM -816.72 % 84.66 % 86.1 % 84.42 % 72.37 % 86.82 %
Return on Assets TTM -123.94 % 23.83 % -2.16 % 12.43 % -11.76 % -2.13 %
Return on Equity TTM -178.68 % 86.4 % -2.88 % 16.85 % -16.53 % -2.75 %
Return on Capital Employed TTM -158.96 % 62.74 % -1.72 % 11.85 % -16.87 % -8.98 %
Net Income Per EBT TTM 100.05 % 79.43 % -184.82 % 93.66 % 100.55 % 167.72 %
EBT Per Ebit TTM 96.2 % 100.52 % -82.68 % 124.1 % 94.01 % 15.76 %
EBIT Per Revenue TTM -6894.43 % 43.84 % -2.96 % 28.92 % -36.09 % -17.08 %
Cash Flow To Debt Ratio TTM - 207.5 % - 214.08 % -185.98 % -
Receivables Turnover TTM - 3.89 6.06 2.27 1.98 3.45
Payables Turnover TTM 5.88 1.72 3.73 4.34 1.54 1.06
Inventory Turnover TTM - 1.09 1.37 0.71 0.65 0.91
Fixed Asset Turnover TTM 6.59 % 225.8 % 422.11 % 311.93 % 256.83 % 6116.64 %
Asset Turnover TTM 1.87 % 68.08 % 47.71 % 36.98 % 34.46 % 47.09 %
Operating Cash Flow Per Share TTM -1.19 26.54 -3.27 39.29 -1.12 -2.42
Free Cash Flow Per Share TTM -1.24 15.14 -4.51 31.25 -1.62 -3.52
Cash Per Share TTM 78.87 % 1681.33 % 2528.88 % 9062.44 % 657.5 % 5163.05 %
Operating Cash Flow Sales Ratio TTM -5283.28 % 43.69 % -7.94 % 30.67 % -16.85 % -6.44 %
Free Cash Flow Operating Cash Flow Ratio TTM 104.1 % 57.03 % 138.12 % 79.52 % 144.14 % 145.12 %
Cash Flow Coverage Ratios TTM - 207.5 % - 214.08 % -185.98 % -
Price To Free Cash Flows Ratio TTM -0.14 38.76 -90.32 22.86 -141.85 -180.06
Price To Operating Cash Flows Ratio TTM -0.15 23.46 -124.98 18.18 -203.89 -260.09
Price Cash Flow Ratio TTM -0.15 23.46 -124.98 18.18 -203.89 -260.09
Income Statement (TTM)
LYRA NVO VRTX REGN SGEN ARGX
Revenue $0B $232.26B $9.87B $13.12B $1.96B $1.23B
Gross Profit $0B $196.5B $8.61B $11.3B $1.55B $1.11B
Gross Profit Ratio 100% 84.6% 87.21% 86.16% 79.1% 90.39%
EBITDA $-0.07B $114.63B $4.61B $4.69B $-0.62B $-0.22B
Net Income $-0.06B $83.68B $3.62B $3.95B $-0.61B $-0.3B
EPS Diluted -1.26 18.62 13.89 34.77 -3.3 -5.16
Balance Sheet (MRQ)
LYRA NVO VRTX REGN SGEN ARGX
Long Term Debt $0.02B $20.53B $1.45B $2.7B $0.04B $0.02B
Total Liabilities $0.05B $207.93B $5.15B $7.11B $0.87B $0.44B
Total Equity $0.09B $106.56B $17.58B $25.97B $2.8B $4.1B
Total Investments $0.08B $17.5B $3.45B $13.51B $1.42B $1.18B
Total Debt $0.03B $27.01B $0.81B $2.7B $0.04B $0.02B
Total Assets $0.14B $314.49B $22.73B $33.08B $3.67B $4.54B
Cash Flow Statement (TTM)
LYRA NVO VRTX REGN SGEN ARGX
Net Income $-0.06B $83.68B $3.62B $3.95B $-0.61B $-0.43B
Inventory $0B $-7.42B $-0.32B $-0.27B $-0.23B $-0.08B
Dividends Paid $0B $-31.77B $0B $0B $0B $0B
Operating Cash Flow $-0.06B $108.91B $3.54B $4.59B $-0.45B $-0.42B
Capital Expenditure $-0B $-38.9B $-0.26B $-0.93B $-0.08B $-0.04B
Related Stocks
Ticker Name Price
AADI Aadi Bioscience, Inc. 3
ABCL AbCellera Biologics Inc. 2.95
ABCM Abcam plc 23.99
ABEO Abeona Therapeutics Inc. 5.68
ABIO ARCA biopharma, Inc. 28.8
ABOS Acumen Pharmaceuticals, Inc. 1.79
ABPWW 0.12
ABSI Absci Corporation 3.01
ABUS Arbutus Biopharma Corporation 3.18
ABVC ABVC BioPharma, Inc. 0.51
ABVX Abivax SA American Depositary Shares 7.6
ACAD ACADIA Pharmaceuticals Inc. 17.07
ACER Acer Therapeutics Inc. 0.6601
ACET Adicet Bio, Inc. 0.9162
ACGN Aceragen, Inc. 0.3849
ACHL Achilles Therapeutics plc 1.14
ACHV Achieve Life Sciences, Inc. 3.79
ACIU AC Immune SA 2.68
ACLX Arcellx, Inc. 77.58
ACRV Acrivon Therapeutics, Inc. Common Stock 6.23
ETFs With Exposure to LYRA
Ticker ETF Name Weight Percentage Price
IWM iShares Russell 2000 ETF 0.00059 223.39
VTI Vanguard Total Stock Market Index Fund 0 297.12
IWO iShares Russell 2000 Growth ETF 0.00058 291.97
VXF Vanguard Extended Market Index Fund 0 193.275
HDG ProShares Hedge Replication ETF 0.0000439245 49.36
UWM ProShares Ultra Russell2000 0.000120772 42.74
IWC iShares Micro-Cap ETF 0.00208 130.01
DWAS Invesco DWA SmallCap Momentum ETF 0.018 92.59
URTY ProShares UltraPro Russell2000 0.0000571026 50.7931
VTWV Vanguard Russell 2000 Value Index Fund 0 145.8
VTWG Vanguard Russell 2000 Growth Index Fund 0 213.7
VTWO Vanguard Russell 2000 Index Fund 0 90.37
VITNX Vanguard Institutional Total Stock Market Index Fund Institutional Shares 0 103.36
VITPX Vanguard Institutional Total Stock Market Index Fund Institutional Plus Shares 0 103.33
VBAIX Vanguard Balanced Index Fund Institutional Shares 0 50.83
VBIAX Vanguard Balanced Index Fund Admiral Shares 0 50.82
VBINX Vanguard Balanced Index Fund Investor Shares 0 50.82
PQSG PGIM ETF Trust - PGIM QMA Strategic Alpha Small-Cap Growth ETF 0.14 72.5283
DFAU Dimensional US Core Equity Market ETF 0.00000991 41.385
DFUS Dimensional U.S. Equity ETF 0.0000173 65.265
DFAT Dimensional U.S. Targeted Value ETF 0.00008 55.8701
DFAS Dimensional U.S. Small Cap ETF 0.00006233 65.67
DFAC Dimensional U.S. Core Equity 2 ETF 0.00002207 35.21
VTSAX Vanguard Total Stock Market Index Fund 0 144.66
VIEIX Vanguard Extended Market Index Fund Institutional Shares 0 146.99
VITSX Vanguard Total Stock Market Index Fund 0 144.68
DFSU Dimensional US Sustainability Core 1 ETF 0 38.69
SWTSX Schwab Total Stock Market Index Fd Select Shs a Series of Schwab Capit 0.0000127257 101.65
VEXAX Vanguard Extended Market Index Fd Admiral Shs 0 147
DCOR Dimensional ETF Trust 0.00000067 65.34
VEMPX Vanguard Extended Market Index InstlPlus 0 362.75
VSMPX Vanguard Total Stock Mkt Idx Instl Pls 0 271.4
RSSL Global X Funds 0 87.98
Unlock